22 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26745812	8	Arylpiperidines as a new class of oxidosqualene cyclase inhibitors.	Ludwig-Maximilians University
23583910	24	Aminopropylindenes derived from Grundmann's ketone as a novel chemotype of oxidosqualene cyclase inhibitors.	Ludwig-Maximilians-Universit£T M£Nchen
17760433	37	Influence of conformation on GRIND-based three-dimensional quantitative structure-activity relationship (3D-QSAR).	Universit£
17981368	22	GRIND-based 3D-QSAR to predict inhibitory activity for similar enzymes, OSC and SHC.	Casmedchem Laboratory
22533316	10	Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells.	Centre Hospitalier Universitaire Vaudois (Chuv) and University of Lausanne (Unil
17027267	9	Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase.	Universit£
12852766	22	Synthesis and structure-activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors.	F. Hoffmann-La Roche
22137785	6	Inhibitors of human 2,3-oxidosqualene cyclase (OSC) discovered by virtual screening.	Institute of Microbial Chemistry
20728352	5	Novel pyrrole- and 1,2,3-triazole-based 2,3-oxidosqualene cyclase inhibitors.	Institute of Microbial Chemistry
	4	Inhibition of oxidosqualene cyclase by substituted quinolizidines	TBA
19119009	75	Oxidosqualene cyclase from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii and Arabidopsis thaliana expressed in yeast: a model for the development of novel antiparasitic agents.	Università
18467104	13	Design and evaluation of a novel series of 2,3-oxidosqualene cyclase inhibitors with low systemic exposure, relationship between pharmacokinetic properties and ocular toxicity.	Laboratoire Glaxosmithkline
13678402	12	Oxidosqualene cyclase inhibitors as antimicrobial agents.	University of Utah
12747780	56	Binding structures and potencies of oxidosqualene cyclase inhibitors with the homologous squalene-hopene cyclase.	Albert-Ludwigs-University of Freiburg
11150166	12	A novel series of 4-piperidinopyridine and 4-piperidinopyrimidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase.	Astrazeneca
9484504	14	29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.	Università
9003518	23	Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase.	Simon Fraser University
24269162	84	NAD-based inhibitors with anticancer potential.	University of Minnesota
23937979	6	Discovery of N-(2,3,5-triazoyl)mycophenolic amide and mycophenolic epoxyketone as novel inhibitors of human IMPDH.	Hokkaido University
30322754	48	Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles.	The University of Queensland
29771525	4	NMR Biochemical Assay for Oxidosqualene Cyclase: Evaluation of Inhibitor Activities on Trypanosoma cruzi and Human Enzymes.	National Institute of Advanced Industrial Science and Technology (Aist)